Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency.

Sci Rep · 2020 · PMC7184591 · PMID 32341402

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Serum from animals treated with modified mRNA displayed a trend of higher inhibitory capacity compared to PBS control animals although this did not reach statistical significance (Fig. 5e ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.